Tevogen Bio Holdings Inc.
TVGN
$0.9922
-$0.0178-1.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 162.87% | -36.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 53.86% | -29.23% | |||
| Operating Income | -53.86% | 29.23% | |||
| Income Before Tax | -60.51% | 39.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -60.51% | 39.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -60.51% | 39.11% | |||
| EBIT | -53.86% | 29.23% | |||
| EBITDA | -54.22% | 29.37% | |||
| EPS Basic | -154.18% | 11.93% | |||
| Normalized Basic EPS | -156.02% | 44.90% | |||
| EPS Diluted | -154.18% | 13.25% | |||
| Normalized Diluted EPS | -156.02% | 44.90% | |||
| Average Basic Shares Outstanding | -37.31% | 10.38% | |||
| Average Diluted Shares Outstanding | -37.31% | 10.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||